pomalidomide has been researched along with paclitaxel in 3 studies
Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
623 | 121 | 552 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cheng, CW; Lin, HW; Sun, F; Tang, J; Tang, WZ; Wang, SP; Wu, W; Yang, F; Yang, ZZ | 1 |
Bian, J; Li, L; Li, Z; Meng, Y; Wang, J; Xu, P; Xu, X | 1 |
Qi, Z; Wang, X; Zhao, Y | 1 |
3 other study(ies) available for pomalidomide and paclitaxel
Article | Year |
---|---|
Imidazole Alkaloids and Their Zinc Complexes from the Calcareous Marine Sponge Leucetta chagosensis.
Topics: A549 Cells; Alkaloids; Animals; Antifungal Agents; Cell Line, Tumor; China; Humans; Imidazoles; Interleukin-6; MCF-7 Cells; Porifera; THP-1 Cells; Zinc | 2018 |
Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.
Topics: Animals; Benzophenanthridines; Benzoquinones; Catalytic Domain; Cell Line, Tumor; Drug Discovery; Enzyme Inhibitors; Glutaminase; Humans; Mice; Molecular Docking Simulation; Protein Binding; Sulfides; Thiadiazoles; Thiazolidinediones | 2019 |
LY103, a pomalidomide derivative, alleviates taxol resistance in NSCLC via energy metabolism crosstalk and tumor microenvironment intervention.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Energy Metabolism; Humans; Lung Neoplasms; Molecular Docking Simulation; Paclitaxel; Tumor Microenvironment | 2023 |